Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVTX

Avalo Therapeutics Inc

18.20

Jun 26 • 04:00PM ET +0.20 (1.11%)

Healthcare Biotechnology USA Small NASD

Peers: KYMR NUVL RYTM INCY BMRN VKTX KRYS AXSM MDGL NBIX

| Held by: XBI VTI VXF IWC ITOT LABU TMSL BBC RSSL DFAS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.82	Insider Own	8.98%	Shs Outstand	52.57M	Perf Week	23.81%
Market Cap	956.69M	Forward P/E	-	EPS next Y	-3.03	Insider Trans	-6.35%	Shs Float	47.84M	Perf Month	15.26%
Enterprise Value	876.88M	PEG	-	EPS next Q	-0.62	Inst Own	76.36%	Short Float	15.50%	Perf Quarter	30.47%
Income	-84.74M	P/S	15944.83	EPS this Y	47.12%	Inst Trans	23.48%	Short Ratio	4.26	Perf Half Y	-2.52%
Sales	0.06M	P/B	6.56	EPS next Y	1.73%	ROA	-71.09%	Short Interest	7.41M	Perf YTD	0.22%
Book/sh	2.77	P/C	11.65	EPS next 5Y	21.15%	ROE	-88.76%	52W High	24.27 -25.01%	Perf Year	282.35%
Cash/sh	1.56	P/FCF	-	EPS past 3/5Y	82.35% 70.20%	ROIC	-120.51%	52W Low	4.53 301.77%	Perf 3Y	-84.83%
Dividend Est.	0.01 (0.06%)	EV/EBITDA	-	Sales past 3/5Y	-85.16% -61.19%	Gross Margin	-283.05%	Volatility	8.45% 7.32%	Perf 5Y	-99.82%
Dividend TTM	-	EV/Sales	14614.67	EPS Y/Y TTM	-1121.44%	Oper. Margin	-134164.41%	ATR (14)	1.19	Perf 10Y	-99.74%
Dividend Ex-Date	-	Quick Ratio	7.66	Sales Y/Y TTM	-86.62%	Profit Margin	-143627.12%	RSI (14)	64.44	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.66	EPS Q/Q	21.93%	SMA20	20.70%	Beta	0.77	Target Price	45.25
Payout	-	Debt/Eq	0.03	Sales Q/Q	-	SMA50	14.78%	Rel Volume	4.92	Prev Close	18.00
Employees	33	LT Debt/Eq	0.03	Earnings	May 13 BMO	SMA200	15.69%	Avg Volume	1.74M	Price	18.20
IPO	Nov 13, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.42% -	Trades		Volume	8,560,612	Change	1.11%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)